Peptide Cancer Vaccine Market: Future Demand, CAGR Growth 23.3%, Market Analysis & Outlook to 2027 : VAXON Biotech, TapImmune, Sellas, Etc.
The Global Peptide Cancer Vaccine Market is expected to grow at a CAGR of roughly 23.3% over the forecast period, growing from USD 280.45 million in 2019 to surpass USD 1.46 billion in 2027.
View full press release